INITIATOR-SPECIFIC PROMOTION OF HEPATOCARCINOGENESIS BY WY-14,643 AND CLOFIBRATE

被引:22
作者
CATTLEY, RC
KATO, M
POPP, JA
TEETS, VJ
VOSS, KS
机构
[1] Chemical Industry Institute of Toxicology
[2] Daiichi Pharmaceutical Co. Ltd., Tokyo
[3] Sterling Winthrop Pharmaceutical Research Division, Collegeville PA
[4] Harvard University School of Public Health, Boston, MA
关键词
D O I
10.1093/carcin/15.8.1763
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The possibility that selection of an initiating agent could have a significant impact on the ability to detect subsequent promoting activity of peroxisome proliferators was examined, Initiation was achieved by established methods using 2-acetylaminofluorene (2-AAF: 0.02% in diet for 8 weeks) or diethylnitrosamine (DEN; 150 mg/kg body wt by single i.p. injection) in male F344 rats. Following initiation, the peroxisome proliferators WY-14,643 or clofibrate were each fed (0.1% of diet) for up to 37 weeks. Both WY-14,643 and clofibrate lacked promoting activity, as measured by increases in the volume density of homogeneous basophilic foci and incidence or multiplicity of hepatocellular neoplasia following 2-AAF initiation compared to non-initiated controls. These negative results sharply contrasted with the observed promoting activity of dietary WY-14,643 and clofibrate following DEN initiation. Peroxisome proliferation, measured as induction of acyl-CoA oxidase activity, was consistently observed in peroxisome proliferator-fed rats despite prior initiation with 2-AAF or DEN. These results suggest that detection of promoting activity for peroxisome proliferators depends on selection of the initiating agent.
引用
收藏
页码:1763 / 1766
页数:4
相关论文
共 33 条
  • [1] AGE-RELATED SUSCEPTIBILITY TO THE CARCINOGENIC EFFECT OF THE PEROXISOME PROLIFERATOR WY-14,643 IN RAT-LIVER
    CATTLEY, RC
    MARSMAN, DS
    POPP, JA
    [J]. CARCINOGENESIS, 1991, 12 (03) : 469 - 473
  • [2] CATTLEY RC, 1989, CANCER RES, V49, P3246
  • [3] POSSIBLE MECHANISMS IN HEPATOCARCINOGENESIS BY THE PEROXISOME PROLIFERATOR DI(2-ETHYLHEXYL)PHTHALATE
    CONWAY, JG
    CATTLEY, RC
    POPP, JA
    BUTTERWORTH, BE
    [J]. DRUG METABOLISM REVIEWS, 1989, 21 (01) : 65 - 102
  • [4] LACK OF COVALENT BINDING OF PEROXISOME PROLIFERATORS NAFENOPIN AND WY-14 643 TO DNA INVIVO AND INVITRO
    GOEL, SK
    LALWANI, ND
    FAHL, WE
    REDDY, JK
    [J]. TOXICOLOGY LETTERS, 1985, 24 (01) : 37 - 43
  • [5] P-32-POSTLABELING ANALYSIS OF PEROXISOME PROLIFERATOR-DNA ADDUCT FORMATION IN RAT-LIVER INVIVO AND HEPATOCYTES INVITRO
    GUPTA, RC
    GOEL, SK
    EARLEY, K
    SINGH, B
    REDDY, JK
    [J]. CARCINOGENESIS, 1985, 6 (06) : 933 - 936
  • [6] KASAI H, 1989, CANCER RES, V49, P2603
  • [7] KRAUPPGRASL B, 1990, CANCER RES, V50, P3701
  • [8] MARONPOT R R, 1986, Toxicologic Pathology, V14, P263
  • [9] MARSMAN D S, 1989, Proceedings of the American Association for Cancer Research Annual Meeting, V30, P193
  • [10] MARSMAN DS, 1988, CANCER RES, V48, P6739